Ferriprox (3 Times A Day) (Deferiprone) Patent Expiration, LOE Window & CMS Spending

Ferriprox (3 Times A Day) (Deferiprone) by Chiesi Usa: FDA Orange Book LOE 2028-04-30, 3 AB generics, $5.4M 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorChiesi Usa
FDA Application & PathwayN021825 (NDA)
Exclusivity / Cliff HorizonNear-Term Cliff (2028-2030)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2028-04-30
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors3
2024 CMS Total Public Spend$5.4M
2024 Medicare Part D Spend$2.2M
2024 Medicaid Spend$3.2M
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel